| VATICANOLH | VATICANOLH | |
| VATICANOLA | VATICANOLA | |
| VATICANOLI | VATICANOLI | |
| VASTAK | VASTAK | |
| VCAA protocol | VCAA protocol | |
| Vat Military Blue CD02 | Vat Military Blue CD02 | |
| Vat Navy Blue VH | Vat Navy Blue VH | |
| Vat Navy Blue BR Powder | Vat Navy Blue BR Powder | |
| VCAD regimen | VCAD regimen | |
| V-ATPase, subunit D | V-ATPase, subunit D | |
| V-ATPASE,RABBITANTI- | V-ATPASE,RABBITANTI- | |
| Vat Olive Green B Paste | Vat Olive Green B Paste | |
| Vat Olive R | Vat Olive R | |
| Vat Olive 3G | Vat Olive 3G | |
| Vat Olive B | Vat Olive B | |
| Vat Black 25 | 3-(Anthrachinon-1-ylamino)anthra[2,1,9-mna]naphth[2,3-h]acridin-5,10,15(16H)-trion | 4395-53-3 |
| Vat Orange 1 | Dibromdibenzo[b,def]chrysen-7,14-dion | 1324-11-4 |
| Vat Orange 11 | 6,18-Dihydrodinaphtho[2,3-i:2',3'-i']benzo[1,2-a:4,5-a']dicarbazol-5,7,12,17,19,24-hexon | 2172-33-0 |
| Vat Orange 3 | 4,10-Dibromdibenzo[def,mno]chrysen-6,12-dion | 4378-61-4 |
| Vat Orange 9 | Pyranthren-8,16-dion | 128-70-1 |
| Vat Orange 7 | Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthrolin-8,17-dion | 4424-06-0 |
| Vat Orange 21 | Vat Orange 21 | 1328-39-8 |
| Vat Orange 20 | Vat Orange 20 | 6370-69-0 |
| Vat orange 26 | Vat orange 26 | 12237-49-9 |
| VATORANGE | VATORANGE | |
| VATORANGEI | VATORANGEI | |
| Vat Orange 4 | Tribrompyranthren-8,16-dion | 1324-33-0 |
| Vat Orange 1, Solubilized | Dinatriumdibromdibenzo[b,def]chrysen-7,14-diylbis(sulfat) | 1324-15-8 |
| Vat Orange 16 | Vat Orange 16 | 10142-57-1 |
| Vat Orange RF Paste | Vat Orange RF Paste | |
| Vat Orange 3G | Vat Orange 3G | |
| Vat Orange 15 | Vat Orange 15 | 2379-78-4 |
| Vat Orange 2 | Dibrompyranthren-8,16-dion | 1324-35-2 |
| Vat Pink 3B Paste | Vat Pink 3B Paste | |
| Vat Pink R Paste | Vat Pink R Paste | |
| Vat protein | Vat protein | |
| VAT-1 protein | VAT-1 protein | |
| Vat Red 10 | Vat Red 10 | 2379-79-5 |
| Vat Red 42 | N,N'-(9,10-Dihydro-9,10-dioxoanthracen-1,4-diyl)bisbenzamid | 2987-68-0 |
| Vat Red Violet RRN Paste | Vat Red Violet RRN Paste | |
| Vat Red Brown G2RN | Vat Red Brown G2RN | |
| Vat Red 5 GK | Vat Red 5 GK | |
| Vat Red Brown RRK | Vat Red Brown RRK | |
| Vat Red 5BF | Vat Red 5BF | |
| Vat Red Brown 5RF | Vat Red Brown 5RF | |
| Vat Red 6B | Vat Red 6B | |
| Vat Red 41 | 2-(3-oxobenzo[b]thien-2(3H)-yliden)benzo[b]thiophen-3(2H)-on | 522-75-8 |
| Vat Red 15 | Bisbenzimidazo[2,1-b:1',2'-j]benzo[lmn][3,8]phenanthrolin-6,9-dion | 4216-02-8 |
| Vat Red 32 | Vat Red 32 | 2379-77-3 |
| Vat Red 48 | Vat Red 48 | |
| Vat Red 20 | Vat Red 20 | 6371-49-9 |
| Vat Red 38 | Vat Red 38 | 6219-99-4 |
| VAT RED 13 | VAT RED 13 | 4392-71-6 |
| Vat Red 54 | Vat Red 54 | |
| VATRED R | VATRED R | |
| Vat Red Brown BRN | Vat Red Brown BRN | |
| Vat Red BN | Vat Red BN | |
| Vat Red 14 | Bisbenzimidazobenzo[lmn][3,8]phenanthrolindion | 8005-56-9 |
| Vat Red 1, Solubilized | Dinatrium-6,6'-dichlor-4,4'-dimethyl[2,2'-bibenzo[b]thiophen]-3,3'-diyldisulfat | 3875-72-7 |
| Vat Red 31 | Vat Red 31 | 12227-47-3 |
| Vav3
| Vav3
| |
| Vav2
| Vav2
| |
| Vat Scarlet GGN Paste | Vat Scarlet GGN Paste | |
| Vat Scarlet Red G | Vat Scarlet Red G | |
| Vav3 (A)
| Vav3 (A)
| |
| vavain 3'-O-glucoside | vavain 3'-O-glucoside | |
| vavain | vavain | |
| Vav3 (B)
| Vav3 (B)
| |
| vaulen | vaulen | 109767-28-4 |
| Vat Violet 13 | Benzo[1,2-c:4,5-c']diacridin-6,9,15,18(5H,14H)-tetron | 4424-87-7 |
| Vat Violet 10 | Benzo[rst]phenanthro[10,1,2-cde]pentaphen-9,18-dion | 128-64-3 |
| Vat Violet 1, Solubilised | Dinatriumdichlorbenzo[rst]phenanthro[10,1,2-cde]pentaphen-9,18-diyldisulfat | 1324-57-8 |
| Vat Violet 1 | Dichlorbenzo[rst]phenanthro[10,1,2-cde]pentaphen-9,18-dion | 1324-55-6 |
| Vat Violet RR | Vat Violet RR | |
| Vat Violet 2R Paste | Vat Violet 2R Paste | |
| VCAM-1 (Ab-3) Monoclonal Antibody | VCAM-1 (Ab-3) Monoclonal Antibody | |
| VCAM-1, CD106, Clone: MK2, Rat Mab anti-Mouse
| VCAM-1, CD106, Clone: MK2, Rat Mab anti-Mouse
| |
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, FITC
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, FITC
| |
| VCAM-1, CD106, Clone: 1G11B1, Mab anti-Human
| VCAM-1, CD106, Clone: 1G11B1, Mab anti-Human
| |
| VCAM-1, CD106,INCAM-110,Clone: 1.G11B1, Mab anti-Human, Rhesus, Sw,frozen,IH/flow/ELISA/IP/WB/Inhibits adhesion
| VCAM-1, CD106,INCAM-110,Clone: 1.G11B1, Mab anti-Human, Rhesus, Sw,frozen,IH/flow/ELISA/IP/WB/Inhibits adhesion
| |
| VCAM-1, CD106, Clone: 1G11B1, Mab anti-Human, Biotin
| VCAM-1, CD106, Clone: 1G11B1, Mab anti-Human, Biotin
| |
| VCAM-1, CD106, 110kD, Clone: 1.4C3, Mab anti-Human, frozen/paraffin, IH/NO WB
| VCAM-1, CD106, 110kD, Clone: 1.4C3, Mab anti-Human, frozen/paraffin, IH/NO WB
| |
| VCAM-1, CD106, 100-110kD, Clone: B495 (B-K9), Mab anti-Human, frozen/paraffin, IH/flow/ELISA
| VCAM-1, CD106, 100-110kD, Clone: B495 (B-K9), Mab anti-Human, frozen/paraffin, IH/flow/ELISA
| |
| VCAM-1, CD106, INCAM-110, Clone: 1E5, Mab anti-Human, frozen, IH/ELISA/IP
| VCAM-1, CD106, INCAM-110, Clone: 1E5, Mab anti-Human, frozen, IH/ELISA/IP
| |
| VCAM-1, CD106, INCAM-110, Endothelial Cell, Clone: 1.4C3, Mab anti-Human, frozen/paraffin,IH/NO effect on adhesion
| VCAM-1, CD106, INCAM-110, Endothelial Cell, Clone: 1.4C3, Mab anti-Human, frozen/paraffin,IH/NO effect on adhesion
| |
| VCAM-1, CD106, INCAM-110, Clone: 1.G11B1,Mab anti-Human, Swine,FITC, flow/Inhibits adhesion
| VCAM-1, CD106, INCAM-110, Clone: 1.G11B1,Mab anti-Human, Swine,FITC, flow/Inhibits adhesion
| |
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, frozen, IH/flow/ELISA/IP
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, frozen, IH/flow/ELISA/IP
| |
| VCAM-1, CD106, INCAM-110,Clone: 1.G11B1,Mab anti-Human, Swine, Biotin, frozen, IH/flow/Inhibits adhesion
| VCAM-1, CD106, INCAM-110,Clone: 1.G11B1,Mab anti-Human, Swine, Biotin, frozen, IH/flow/Inhibits adhesion
| |
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, frozen
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, frozen
| |
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, Biotin
| VCAM-1, CD106, 110kD, Clone: 1.G11B1, Mab anti-Human, Biotin
| |
| VCAM, CD106, Mab anti-Human, frozen/paraffin (w/NB reag.)
| VCAM, CD106, Mab anti-Human, frozen/paraffin (w/NB reag.)
| |
| VCAM-1, CD106, INCAM-110, Clone: 1.G11B1, Mab anti-Human, frozen, IH/flow/ELISA/IP/Inhibits adhesion
| VCAM-1, CD106, INCAM-110, Clone: 1.G11B1, Mab anti-Human, frozen, IH/flow/ELISA/IP/Inhibits adhesion
| |
| VCAM-1, CD106, Clone: MK2, Rat Mab anti-Mouse, Biotin
| VCAM-1, CD106, Clone: MK2, Rat Mab anti-Mouse, Biotin
| |
| Vat Voilet 3 | Vat Voilet 3 | 2379-75-1 |
| VBL(C.I.85) | VBL(C.I.85) | |
| Vault Ribonucleoprotein Particles | Vault Ribonucleoprotein Particles | |
| VCAM-1 Monoclonal Antibody
| VCAM-1 Monoclonal Antibody
| |
| VAV1-D1 Fusion Protein(SH3)
| VAV1-D1 Fusion Protein(SH3)
| |
| VCAM345 peptide | VCAM345 peptide | |
| V-CAM protocol | V-CAM protocol | |